Suppr超能文献

海洛因使用障碍患者阿片类药物治疗期间应激敏感性的特征。

Characteristics of Stress Sensitivity in Heroin Use Disorder Patients during Their Opioid Agonist Treatment.

机构信息

Addiction Research Methods Institute, World Federation for the Treatment of Opioid Dependence, 225 Varick Street, Suite 402, New York, NY 10014, USA.

Department of Psychiatry and Addictions, Section of Psychiatry, North-Western Tuscany Local Health Unit, Tuscany NHS, Versilia Zone, Via Aurelia 335, 55041 Viareggio, Italy.

出版信息

Int J Environ Res Public Health. 2023 Mar 4;20(5):4566. doi: 10.3390/ijerph20054566.

Abstract

In the present study, performed on a sample of Heroin Use Disorder (HUD) patients undergoing Opioid Agonist Treatment (OAT), we attempted to explore the relationships between stress sensitivity and heroin addiction-related clinical aspects. HUD patients' stress sensitivity was evaluated with the Heroin/PTSD-Spectrum questionnaire (H/PSTD-S). The Drug Addiction History Questionnaire (DAH-Q), the Symptomatological Check List-90 (SCL-90), and The Behavioural Covariate of Heroin Craving inventory (CRAV-HERO) were all used, as were the Deltito Subjective Wellness Scale (D-SWS), a self-report scale evaluating subjective well-being; the Cocaine Problem Severity Index (CPSI), a questionnaire determining the extent of a cocaine problem; and the Marijuana Craving Questionnaire (MC-Q), an instrument assessing craving for cannabinoids. We checked correlations between stress sensitivity and the extent of HUD clinical features and compared patients with and without problematic stress sensitivity. H/PTSD-S was positively correlated with patients' income, altered mental status, legal problems, the lifetime different treatments index, the current treatment load index, and all SCL-90 indexes and factors. Regarding subjective well-being, stress sensitivity negatively correlated with the contrast best week (last five years) index. Patients with high-stress sensitivity were females with a low income. They exhibited a more severe mental status at treatment entry, greater difficulty in working adaptation, and legal problems during treatment. Additionally, these patients showed a higher level of psychopathology, more impairment in well-being, and more risky behaviours during treatment. Stress sensitivity, as H/PTSD-S, must be considered an outcome of HUD. HUD's addiction history and clinical features are significant risk factors for H/PTSD-S. Therefore, social and behavioural impairment in HUD patients could be considered the clinical expression of the H/PTSD spectrum. In summary, the long-term outcome of HUD is not represented by drug-taking behaviours. Rather, the inability to cope with the contingent environmental conditions is the key feature of such a disorder. H/PTSD-S, therefore, should be seen as a syndrome caused by an acquired inability (increased salience) concerning regular (daily) life events.

摘要

在这项针对接受阿片类激动剂治疗(OAT)的海洛因使用障碍(HUD)患者的样本进行的研究中,我们试图探索应激敏感性与海洛因成瘾相关临床方面之间的关系。HUD 患者的应激敏感性通过海洛因/创伤后应激障碍谱问卷(H/PTSD-S)进行评估。还使用了药物使用史问卷(DAH-Q)、症状清单-90(SCL-90)和海洛因渴求行为变异量表(CRAV-HERO),以及德尔蒂托主观幸福感量表(D-SWS),这是一种评估主观幸福感的自评量表;可卡因问题严重程度指数(CPSI),一种确定可卡因问题严重程度的问卷;以及大麻渴求问卷(MC-Q),一种评估大麻渴求的工具。我们检查了应激敏感性与 HUD 临床特征严重程度之间的相关性,并比较了有和无问题应激敏感性的患者。H/PTSD-S 与患者的收入、改变的精神状态、法律问题、一生不同治疗指数、当前治疗负荷指数以及所有 SCL-90 指数和因素呈正相关。关于主观幸福感,应激敏感性与对比最佳周(过去五年)指数呈负相关。高应激敏感性的患者为女性,收入较低。她们在治疗开始时表现出更严重的精神状态,在工作适应方面更困难,并且在治疗期间存在法律问题。此外,这些患者在治疗期间表现出更高水平的精神病理学、幸福感更受损以及更危险的行为。应激敏感性,如 H/PTSD-S,必须被视为 HUD 的结果。HUD 的成瘾史和临床特征是 H/PTSD-S 的重要危险因素。因此,HUD 患者的社会和行为障碍可被视为 H/PTSD 谱的临床表现。总之,HUD 的长期结果不是由吸毒行为代表的。相反,无法应对偶然的环境条件是这种障碍的关键特征。因此,H/PTSD-S 应被视为一种由后天获得的无法应对(增加的凸显性)日常事件引起的综合征。

相似文献

1
海洛因使用障碍患者阿片类药物治疗期间应激敏感性的特征。
Int J Environ Res Public Health. 2023 Mar 4;20(5):4566. doi: 10.3390/ijerph20054566.
2
移民过程是否会影响移民到意大利的海洛因使用障碍的临床表现?
CNS Spectr. 2021 Feb;26(1):62-70. doi: 10.1017/S1092852919001846. Epub 2020 Jan 23.
4
海洛因和可卡因使用及渴求的日时间模式:与营业时间的关系,而不考虑实际就业状况。
Addict Behav. 2013 Oct;38(10):2485-91. doi: 10.1016/j.addbeh.2013.05.010. Epub 2013 May 22.
6
精神病理亚型对进入住院治疗社区治疗的物质使用障碍患者留存率的影响。
Ann Gen Psychiatry. 2016 Nov 8;15:29. doi: 10.1186/s12991-016-0119-x. eCollection 2016.
7
成瘾的精神病理学:基于症状自评量表90(SCL-90)的五维度结构是否可不管所涉及的药物而应用?
Ann Gen Psychiatry. 2016 Apr 26;15:13. doi: 10.1186/s12991-016-0100-8. eCollection 2016.
8
人类实验室中可卡因、大麻和海洛因的自我给药:益处与陷阱
Addict Biol. 2009 Jan;14(1):9-21. doi: 10.1111/j.1369-1600.2008.00121.x. Epub 2008 Oct 9.
9
用缓释口服吗啡替代治疗阿片类药物依赖:转换用吗啡后保留率、健康状况和物质使用情况。
J Subst Abuse Treat. 2021 Aug;127:108350. doi: 10.1016/j.jsat.2021.108350. Epub 2021 Mar 4.

本文引用的文献

1
独立基层医疗实践中采用减少伤害方法治疗阿片类药物使用障碍:定性研究。
J Gen Intern Med. 2021 Jul;36(7):1898-1905. doi: 10.1007/s11606-020-06409-6. Epub 2021 Jan 19.
2
接受阿片类物质使用障碍药物辅助治疗的男性和女性的社会功能结局
Biol Sex Differ. 2020 Apr 23;11(1):20. doi: 10.1186/s13293-020-00298-4.
3
性别和基于性别的因素对 PTSD 性别差异的影响。
Curr Psychiatry Rep. 2020 Mar 3;22(4):19. doi: 10.1007/s11920-020-1140-y.
4
阿片类药物使用障碍的药物治疗。
Biol Psychiatry. 2020 Jan 1;87(1):82-88. doi: 10.1016/j.biopsych.2019.06.020. Epub 2019 Jul 2.
5
阿片类药物成瘾的神经生物学:对抗过程、超快感和负强化。
Biol Psychiatry. 2020 Jan 1;87(1):44-53. doi: 10.1016/j.biopsych.2019.05.023. Epub 2019 Jun 12.
6
应激反应与青少年物质使用的发展性精神病理学
Neurobiol Stress. 2018 Sep 12;9:133-139. doi: 10.1016/j.ynstr.2018.09.002. eCollection 2018 Nov.
7
阿片类药物治疗中的危害减少:一个受到威胁的既定理念。
Addiction. 2019 Jan;114(1):20-21. doi: 10.1111/add.14468. Epub 2018 Nov 16.
8
活得快,死得早?ADHD 一生发展轨迹综述。
Eur Neuropsychopharmacol. 2018 Oct;28(10):1059-1088. doi: 10.1016/j.euroneuro.2018.08.001. Epub 2018 Sep 6.
9
创伤后应激障碍对海洛因依赖康复的长期影响。
J Subst Abuse Treat. 2018 Jun;89:60-66. doi: 10.1016/j.jsat.2018.04.001. Epub 2018 Apr 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验